Queen Mary Hospital, Department of Medicine

Hong Kong 999077

1 studies enrolling now · 2 studies all time

What they study most

Anaplastic Lymphoma Kinase-positive, Breast Cancer, Non-small Cell Lung Cancer

Studies at this site

• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC — Recruiting now
• Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer — Completed